Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
safety data
Biotech
Takeda stops narcolepsy clinical trials because of safety signal
Takeda has hit the brakes hard on its narcolepsy program in response to a safety signal, stopping its two midphase clinical trials early.
Nick Paul Taylor
Oct 6, 2021 4:45am
FDA takes note of stroke-preventing heart implant risk in women
Sep 29, 2021 11:56am
Aprea's myeloid program iced by FDA on adverse events
Aug 6, 2021 10:30am
Lumosa's stroke drug lowers risk of deadly complication
Aug 4, 2021 10:35am
FDA expands probe into safety of AstraZeneca's COVID-19 vaccine
Oct 1, 2020 7:30am
AstraZeneca's COVID-19 vaccine pause has NIH 'very concerned'
Sep 16, 2020 7:40am
